Literature DB >> 23897684

Bile acid metabolism and signaling.

John Y L Chiang1.   

Abstract

Bile acids are important physiological agents for intestinal nutrient absorption and biliary secretion of lipids, toxic metabolites, and xenobiotics. Bile acids also are signaling molecules and metabolic regulators that activate nuclear receptors and G protein-coupled receptor (GPCR) signaling to regulate hepatic lipid, glucose, and energy homeostasis and maintain metabolic homeostasis. Conversion of cholesterol to bile acids is critical for maintaining cholesterol homeostasis and preventing accumulation of cholesterol, triglycerides, and toxic metabolites, and injury in the liver and other organs. Enterohepatic circulation of bile acids from the liver to intestine and back to the liver plays a central role in nutrient absorption and distribution, and metabolic regulation and homeostasis. This physiological process is regulated by a complex membrane transport system in the liver and intestine regulated by nuclear receptors. Toxic bile acids may cause inflammation, apoptosis, and cell death. On the other hand, bile acid-activated nuclear and GPCR signaling protects against inflammation in liver, intestine, and macrophages. Disorders in bile acid metabolism cause cholestatic liver diseases, dyslipidemia, fatty liver diseases, cardiovascular diseases, and diabetes. Bile acids, bile acid derivatives, and bile acid sequestrants are therapeutic agents for treating chronic liver diseases, obesity, and diabetes in humans.
© 2013 American Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23897684      PMCID: PMC4422175          DOI: 10.1002/cphy.c120023

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  224 in total

Review 1.  FXR, a bile acid receptor and biological sensor.

Authors:  H Tu; A Y Okamoto; B Shan
Journal:  Trends Cardiovasc Med       Date:  2000-01       Impact factor: 6.677

2.  Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.

Authors:  Tiangang Li; Michelle Matozel; Shannon Boehme; Bo Kong; Lisa-Mari Nilsson; Grace Guo; Ewa Ellis; John Y L Chiang
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

3.  Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle.

Authors:  Emma De Fabiani; Nico Mitro; Federica Gilardi; Donatella Caruso; Giovanni Galli; Maurizio Crestani
Journal:  J Biol Chem       Date:  2003-07-15       Impact factor: 5.157

Review 4.  A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.

Authors:  Bart Staels
Journal:  Postgrad Med       Date:  2009-05       Impact factor: 3.840

5.  Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation.

Authors:  Ji Miao; Zhen Xiao; Deepthi Kanamaluru; Gyesik Min; Peter M Yau; Timothy D Veenstra; Ewa Ellis; Steve Strom; Kelly Suino-Powell; H Eric Xu; Jongsook Kim Kemper
Journal:  Genes Dev       Date:  2009-04-15       Impact factor: 11.361

Review 6.  Nuclear receptors and the control of metabolism.

Authors:  Gordon A Francis; Elisabeth Fayard; Frédéric Picard; Johan Auwerx
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

7.  Expression and function of the bile acid receptor TGR5 in Kupffer cells.

Authors:  Verena Keitel; Markus Donner; Stefanie Winandy; Ralf Kubitz; Dieter Häussinger
Journal:  Biochem Biophys Res Commun       Date:  2008-05-09       Impact factor: 3.575

8.  Liver-specific activities of FGF19 require Klotho beta.

Authors:  Benjamin C Lin; Manping Wang; Craig Blackmore; Luc R Desnoyers
Journal:  J Biol Chem       Date:  2007-07-11       Impact factor: 5.157

9.  Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1.

Authors:  Quan Shang; Monica Saumoy; Jens Juul Holst; Gerald Salen; Guorong Xu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-31       Impact factor: 4.052

10.  Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.

Authors:  Yuan Zhang; Sarah R Breevoort; Jerry Angdisen; Mingui Fu; Daniel R Schmidt; Sam R Holmstrom; Steven A Kliewer; David J Mangelsdorf; Ira G Schulman
Journal:  J Clin Invest       Date:  2012-04-09       Impact factor: 14.808

View more
  355 in total

Review 1.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

Review 2.  Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicity.

Authors:  Frank J Gonzalez; Zhong-Ze Fang; Xiaochao Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-04-02       Impact factor: 4.481

3.  β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.

Authors:  Michael D Thompson; Akshata Moghe; Pamela Cornuet; Rebecca Marino; Jianmin Tian; Pengcheng Wang; Xiaochao Ma; Marc Abrams; Joseph Locker; Satdarshan P Monga; Kari Nejak-Bowen
Journal:  Hepatology       Date:  2018-01-26       Impact factor: 17.425

4.  Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment.

Authors:  Prasant K Jena; Lili Sheng; Hui-Xin Liu; Karen M Kalanetra; Annie Mirsoian; William J Murphy; Samuel W French; Viswanathan V Krishnan; David A Mills; Yu-Jui Yvonne Wan
Journal:  Am J Pathol       Date:  2017-07-12       Impact factor: 4.307

5.  Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity.

Authors:  Prasant Kumar Jena; Lili Sheng; Jacopo Di Lucente; Lee-Way Jin; Izumi Maezawa; Yu-Jui Yvonne Wan
Journal:  FASEB J       Date:  2018-01-10       Impact factor: 5.191

6.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

7.  Changes of the plasma metabolome of newly born piglets subjected to postnatal hypoxia and resuscitation with air.

Authors:  Rønnaug Solberg; Julia Kuligowski; Leonid Pankratov; Javier Escobar; Guillermo Quintás; Isabel Lliso; Ángel Sánchez-Illana; Ola Didrik Saugstad; Máximo Vento
Journal:  Pediatr Res       Date:  2016-04-07       Impact factor: 3.756

8.  Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.

Authors:  Qing Wu; Lulu Sun; Xiaomin Hu; Xuemei Wang; Feng Xu; Bo Chen; Xianyi Liang; Jialin Xia; Pengcheng Wang; Daisuke Aibara; Shaofei Zhang; Guangyi Zeng; Chuyu Yun; Yu Yan; Yicheng Zhu; Michael Bustin; Shuyang Zhang; Frank J Gonzalez; Changtao Jiang
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

9.  Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis.

Authors:  Stefano Fiorucci; Eleonora Distrutti; Michele Biagioli
Journal:  Dig Dis Sci       Date:  2021-02-08       Impact factor: 3.199

10.  MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.

Authors:  Young-Chae Kim; Hyunkyung Jung; Sunmi Seok; Yang Zhang; Jian Ma; Tiangang Li; Byron Kemper; Jongsook Kim Kemper
Journal:  Hepatology       Date:  2020-02-14       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.